Jourik Gietema

Professor Medical Oncology, Head of Medical Oncology Department Profile

Professor Medical Oncology, Head of Medical Oncology Department

I am a board-certified medical oncologist and the head of the department of the Medical Oncology department. My research focuses on interdisciplinary, translational research, late effects and survivor care aiming for personalized medicine. I specialize in urogenital cancer research by performing clinical trials investigating the long-term consequences of testicular cancer diagnosis and treatment. Additionally, I work on early clinical trials with novel anticancer agents, molecular imaging research and survivorship care research.

Discover our research

publication

Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

2024, ESMO Open

publication

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events

2024, ESMO Open

All publications

- Systemic treatment options for testicular cancerJourik Gietema (Invited speaker) 25-Sep-2024 Professional or public presentation > Professional
- Netwerkbijeenkomst Oncologienetwerk Groningen DrentheJourik Gietema (Chair/vice-chair of organising committee) 29-May-2024 Organising and contributing to an event > Professional
- Difficult-to-treat testicular germ cell tumoursJourik Gietema (Invited speaker) 14-Mar-2024 Professional or public presentation > Professional
- The future of OncoLifeSJourik Gietema (Invited speaker) 22-Jan-2024 Academic presentation > Academic
- Systeemtherapie op maat: nu en in de toekomstJourik Gietema (Speaker) 18-Oct-2023 Professional or public presentation > Professional
All activities
- Grant: Optimal timing of a tailored physical activity program during chemotherapeutic cancer treatment to reduce long-term cardiovascular morbidity. (€606.200,--)Annemiek Walenkamp-Hageman, Jourik Gietema, , 2011 Academic
All prizes

Jourik Gietema

Discover our research

Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events

Contact

Footer navigatie

UMCG Research

Researchers

About UMCG

Jourik Gietema

Discover our research

Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events

Activities

Prizes

Contact

UMCG Research

Researchers

About UMCG